Stratos Wealth Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.63M | Sell |
22,636
-2,025
| -8% | -$156K | 0.02% | 621 |
|
|
2025
Q4 | $1.96M | Sell |
24,661
-1,733
| -7% | -$137K | 0.02% | 557 |
|
|
2025
Q3 | $1.99M | Buy |
26,394
+281
| +1% | +$19.3K | 0.02% | 533 |
|
|
2025
Q2 | $1.8M | Sell |
26,113
-964
| -4% | -$63.2K | 0.02% | 528 |
|
|
2025
Q1 | $1.83M | Sell |
27,077
-12,580
| -32% | -$753K | 0.03% | 475 |
|
|
2024
Q4 | $1.78M | Sell |
39,657
-12,673
| -24% | -$711K | 0.03% | 510 |
|
|
2024
Q3 | $3.29M | Buy |
52,330
+5,407
| +12% | +$315K | 0.05% | 346 |
|
|
2024
Q2 | $2.77M | Sell |
46,923
-15,217
| -24% | -$952K | 0.04% | 366 |
|
|
2024
Q1 | $4.96M | Buy |
62,140
+868
| +1% | +$66.3K | 0.08% | 246 |
|
|
2023
Q4 | $4.84M | Sell |
61,272
-4,613
| -7% | -$328K | 0.09% | 230 |
|
|
2023
Q3 | $4.6M | Buy |
65,885
+3,874
| +6% | +$274K | 0.1% | 212 |
|
|
2023
Q2 | $4.29M | Buy |
62,011
+4,072
| +7% | +$290K | 0.1% | 216 |
|
|
2023
Q1 | $4.31M | Sell |
57,939
-13,303
| -19% | -$1.12M | 0.11% | 183 |
|
|
2022
Q4 | $6.64M | Buy |
71,242
+3,327
| +5% | +$321K | 0.17% | 135 |
|
|
2022
Q3 | $6.48M | Sell |
67,915
-3,912
| -5% | -$387K | 0.18% | 114 |
|
|
2022
Q2 | $6.66M | Sell |
71,827
-1,632
| -2% | -$159K | 0.17% | 128 |
|
|
2022
Q1 | $7.43M | Buy |
73,459
+5,354
| +8% | +$562K | 0.17% | 123 |
|
|
2021
Q4 | $7.03M | Sell |
68,105
-2,519
| -4% | -$233K | 0.16% | 139 |
|
|
2021
Q3 | $5.99M | Buy |
70,624
+2,901
| +4% | +$243K | 0.15% | 148 |
|
|
2021
Q2 | $5.65M | Buy |
67,723
+96
| +0.1% | +$7.86K | 0.14% | 162 |
|
|
2021
Q1 | $5.09M | Sell |
67,627
-1,346
| -2% | -$98K | 0.14% | 159 |
|
|
2020
Q4 | $4.71M | Sell |
68,973
-3,240
| -4% | -$211K | 0.14% | 166 |
|
|
2020
Q3 | $4.22M | Sell |
72,213
-4,957
| -6% | -$308K | 0.14% | 165 |
|
|
2020
Q2 | $5.01M | Sell |
77,170
-5,695
| -7% | -$359K | 0.18% | 133 |
|
|
2020
Q1 | $4.92M | Buy |
82,865
+4,039
| +5% | +$270K | 0.23% | 100 |
|
|
2019
Q4 | $5.86M | Buy |
78,826
+1,819
| +2% | +$128K | 0.23% | 93 |
|
|
2019
Q3 | $4.86M | Buy |
77,007
+3,331
| +5% | +$197K | 0.21% | 104 |
|
|
2019
Q2 | $4.01M | Buy |
73,676
+6,624
| +10% | +$357K | 0.17% | 128 |
|
|
2019
Q1 | $3.62M | Buy |
67,052
+2,213
| +3% | +$137K | 0.16% | 139 |
|
|
2018
Q4 | $4.25M | Sell |
64,839
-7,776
| -11% | -$580K | 0.22% | 97 |
|
|
2018
Q3 | $5.72M | Sell |
72,615
-7,456
| -9% | -$533K | 0.26% | 75 |
|
|
2018
Q2 | $5.15M | Sell |
80,071
-9,611
| -11% | -$633K | 0.23% | 87 |
|
|
2018
Q1 | $5.58M | Buy |
89,682
+14,711
| +20% | +$1.06M | 0.23% | 92 |
|
|
2017
Q4 | $5.43M | Sell |
74,971
-3,760
| -5% | -$273K | 0.24% | 83 |
|
|
2017
Q3 | $6.4M | Sell |
78,731
-7,160
| -8% | -$566K | 0.3% | 69 |
|
|
2017
Q2 | $6.91M | Sell |
85,891
-10,614
| -11% | -$838K | 0.36% | 61 |
|
|
2017
Q1 | $7.58M | Buy |
96,505
+17,841
| +23% | +$1.42M | 0.43% | 53 |
|
|
2016
Q4 | $6.21M | Buy |
78,664
+34,405
| +78% | +$2.78M | 0.39% | 57 |
|
|
2016
Q3 | $3.94M | Buy |
44,259
+4,598
| +12% | +$434K | 0.27% | 78 |
|
|
2016
Q2 | $3.8M | Buy |
39,661
+9,352
| +31% | +$932K | 0.28% | 75 |
|
|
2016
Q1 | $3.14M | Buy |
30,309
+2,847
| +10% | +$277K | 0.27% | 68 |
|
|
2015
Q4 | $2.69M | Buy |
27,462
+23,167
| +539% | +$2.27M | 0.22% | 85 |
|
|
2015
Q3 | $414K | Sell |
4,295
-19,603
| -82% | -$2.06M | 0.05% | 294 |
|
|
2015
Q2 | $2.51M | Sell |
23,898
-9,227
| -28% | -$943K | 0.32% | 64 |
|
|
2015
Q1 | $3.42M | Buy |
33,125
+1,804
| +6% | +$183K | 0.41% | 51 |
|
|
2014
Q4 | $3.02M | Sell |
31,321
-2,473
| -7% | -$218K | 0.54% | 44 |
|
|
2014
Q3 | $2.69M | Buy |
33,794
+1,853
| +6% | +$146K | 0.63% | 39 |
|
|
2014
Q2 | $2.41M | Buy |
+31,941
| New | +$2.41M | 0.8% | 32 |
|
Other funds holding CVS
VCM
VPM
Stratos Wealth Partners's CVS Position: Q1 2026 in Review
Stratos Wealth Partners reduced its CVS Health (CVS) stake by 8.2% in Q1 2026, selling an estimated $156K and leaving 22,636 shares worth $1.63M. The position accounts for 0.02% of the portfolio, ranked #621.
Stratos Wealth Partners first reported a position in CVS in Q2 2014 and has held it in 48 quarters since. The position peaked at $7.58M in Q1 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Stratos Wealth Partners held 22,636 shares of CVS Health worth $1.63M as of Q1 2026.
- Stratos Wealth Partners sold 2,025 CVS Health shares in Q1 2026, an estimated $156K.
- CVS Health made up 0.02% of Stratos Wealth Partners's portfolio in Q1 2026, its #621 holding.
- Stratos Wealth Partners first reported a position in CVS Health in Q2 2014 and has held it in 48 quarters since.
- Stratos Wealth Partners's CVS Health position peaked at $7.58M in Q1 2017.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.